Concepedia

Balireddy Akula

BA

Statistics

Publications

2

Citations

94

H-Index

2

Active since

2014

Affiliations

Icahn School of Medicine at Mount Sinai(Current)

Onconova Therapeutics (United States)

Balireddy Akula is an author at Icahn School of Medicine at Mount Sinai specializing in drug discovery, medicinal chemistry, and pharmacotherapy.

Top concepts

Publications per year

2014–2015

2

Publications

2

Discovery of 8-Cyclopentyl-2-[4-(4-methyl-piperazin-1-yl)-phenylamino]-7-oxo-7,8-dihydro-pyrido[2,3-<i>d</i>]pyrimidine-6-carbonitrile (<b>7x</b>) as a Potent Inhibitor of Cyclin-Dependent Kinase 4 (CDK4) and AMPK-Related Kinase 5 (ARK5)

M. V. Ramana Reddy, Balireddy Akula, Stephen C. Cosenza et al. · Journal of Medicinal Chemistry · 2014 · 70 citations · Full text

Discovery of 2-(1H-indol-5-ylamino)-6-(2,4-difluorophenylsulfonyl)-8-methylpyrido[2,3-d]pyrimidin-7(8H)-one (7ao) as a potent selective inhibitor of Polo like kinase 2 (PLK2)

M. V. Ramana Reddy, Balireddy Akula, Shashi Jatiani et al. · Bioorganic & Medicinal Chemistry · 2015 · 24 citations · Full text

, , +11

1–2 of 2